Status:
TERMINATED
Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C, Chronic
Hepatitis C
Eligibility:
All Genders
Brief Summary
Adherence to the prescribed treatment regimen with PegIntron and Rebetol affects the chance of achieving a sustained virologic response in patients with hepatitis C. The objective of this study is to ...
Eligibility Criteria
Inclusion
- Treatment-naïve patients with hepatitis C
- Patients treated with PegIntron pen and Rebetol
- Patients receiving patient assistance program
Exclusion
- Not applicable
Key Trial Info
Start Date :
November 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
267 Patients enrolled
Trial Details
Trial ID
NCT00705107
Start Date
November 1 2004
End Date
November 1 2007
Last Update
June 30 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.